Compare HCSG & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCSG | LENZ |
|---|---|---|
| Founded | 1976 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Assisted Living Services | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 852.0M |
| IPO Year | N/A | 2021 |
| Metric | HCSG | LENZ |
|---|---|---|
| Price | $19.36 | $18.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $19.40 | ★ $56.25 |
| AVG Volume (30 Days) | 592.3K | ★ 1.0M |
| Earning Date | 10-22-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,808,303,000.00 | $17,500,000.00 |
| Revenue This Year | $9.23 | N/A |
| Revenue Next Year | $5.55 | $204.72 |
| P/E Ratio | $35.93 | ★ N/A |
| Revenue Growth | ★ 6.26 | N/A |
| 52 Week Low | $9.13 | $15.70 |
| 52 Week High | $20.00 | $50.40 |
| Indicator | HCSG | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 64.26 | 25.09 |
| Support Level | $17.96 | $27.07 |
| Resistance Level | $19.00 | $29.02 |
| Average True Range (ATR) | 0.53 | 2.42 |
| MACD | 0.04 | -0.58 |
| Stochastic Oscillator | 88.24 | 18.08 |
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.